AI Wants to Cure Cancer. This Startup Says the Missing Piece Is Human Data
For years, the AI revolution in medicine has sounded almost too good to be true. Give AI enough biological data, the thinking goes, and perhaps it could help researchers discover drugs faster, predict which treatments will work, and eventually tackle diseases that have frustrated medicine for decades. Cancer is the obvious prize. But there is a problem: AI can only be as good as the biology it learns from.
Explore